FLOWPATH Trademark

Trademark Overview

On Wednesday, February 11, 2026, a trademark application was filed for FLOWPATH with the United States Patent and Trademark Office. The USPTO has given the FLOWPATH trademark a serial number of 99648239. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, February 11, 2026. This trademark is owned by bioAffinity Technologies, Inc.. The FLOWPATH trademark is filed in the Medical Instrument Products category with the following description:

Cancer screening test kit comprised of implements and container for collecting patient biological samples for analysis
flowpath

General Information

Serial Number99648239
Word MarkFLOWPATH
Filing DateWednesday, February 11, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, February 11, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCancer screening test kit comprised of implements and container for collecting patient biological samples for analysis

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, February 11, 2026
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamebioAffinity Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78217

Trademark Events

Event DateEvent Description
Wednesday, February 11, 2026NEW APPLICATION ENTERED
Wednesday, February 11, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

flowpath patient biological samples analysis collecting container screening test comprised implements